MicroRNA-orchestrated pathophysiologic control in gut homeostasis and inflammation

키워드

참고문헌 (67)

1. Kaser A, "Inflammatory bowel disease", Annu Rev Immunol, 28, pp.573~621 (2010)
2. Artis D, "Epithelial-cell recognition of commensal bacteria, maintenance of immune homeostasis in the gut", Nat Rev Immunol, 8, pp.411~420 (2008)
3. Hooper LV, "Immune adaptations that maintain homeostasis with the intestinal microbiota", Nat Rev Immunol, 10, pp.159~169 (2010)
4. Creamer B, "The turnover, shedding of epithelial cells. I. The turnover in the gastro-intestinal tract", Gut, 2, pp.110~118 (1961)
5. Barker N, "Identification of stem cells in small intestine, colon by marker gene Lgr5", Nature, 449, pp.1003~1007 (2007)
6. van der Flier LG, "Transcription factor achaete scute-like 2 controls intestinal stem cell fate", Cell, 136, pp.903~912 (2009)
7. Riccio O, "Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1, Notch2 is accompanied by derepression of CDK inhibitors p27Kip1, p57Kip2", EMBO Rep, 9, pp.377~383 (2008)
8. Guan Y, "Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cells", Am J Physiol Cell Physiol, 300, pp.C1404~C1414 (2011)
9. Nakano K, "PUMA, a novel proapoptotic gene, is induced by p53", Mol Cell, 7, pp.683~694 (2001)
10. Oda E, "Noxa, a BH3-only member of the Bcl-2 family, candidate mediator of p53-induced apoptosis", Science, 288, pp.1053~1058 (2000)
11. Chopra M, "Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death, reduces GVHD", Blood, 126, pp.437~444 (2015)
12. Takahashi N, "RIPK1ensures intestinal homeostasis by protecting the epithelium against apoptosis", Nature, 513, pp.95~99 (2014)
13. Salzman NH, "Enteric defensins are essential regulators of intestinal microbial ecology", Nat Immunol, 11, pp.76~83 (2010)
14. Cash HL, "Symbiotic bacteria direct expression of an intestinal bactericidal lectin", Science, 313, pp.1126~1130 (2006)
15. Koslowski MJ, "Innate antimicrobial host defense in small intestinal Crohn's disease", Int J Med Microbiol, 300, pp.34~40 (2010)
16. Wehkamp J, "Reduced Paneth cell alpha-defensins in ileal Crohn's disease", Proc Natl Acad Sci U S A, 102, pp.18129~18134 (2005)
17. Courth LF, "Crohn's disease-derived monocytes fail to induce Paneth cell defensins", Proc Natl Acad Sci U S A, 112, pp.14000~14005 (2015)
18. Cadwell K, "A key role for autophagy, the autophagy gene Atg16l1 in mouse, human intestinal Paneth cells", Nature, 456, pp.259~263 (2008)
19. Kaser A, "XBP1 links ER stress to intestinal inflammation, confers genetic risk for human inflammatory bowel disease", Cell, 134, pp.743~756 (2008)
20. Ganz T, "Defensins. Natural peptide antibiotics of human neutrophils", J Clin Invest, 76, pp.1427~1435 (1985)
21. Wilde CG, "Purification, characterization of human neutrophil peptide 4, a novel member of the defensin family", J Biol Chem, 264, pp.11200~11203 (1989)
22. O'Neil DA, "Expression, regulation of the human beta-defensins hBD-1, hBD-2 in intestinal epithelium", J Immunol, 163, pp.6718~6724 (1999)
23. Hase K, "Cell differentiation is a key determinant of cathelicidin LL-37", human cationic antimicrobial protein 18 expression by human colon epithelium, 2002, pp.70, 953~963
24. Barrett JC, "Genomewide association defines more than 30 distinct susceptibility loci for Crohn's disease", Nat Genet, 40, pp.955~962 (2008)
25. Van Limbergen J, "The genetics of Crohn's disease", Annu Rev Genomics Hum Genet, 10, pp.89~116 (2009)
26. Imielinski M, "Common variants at five new loci associated with early-onset inflammatory bowel disease", Nat Genet, 41, pp.1335~1340 (2009)
27. Peake ST, "Mechanisms of action of anti-tumor necrosis factor alpha agents in Crohn's disease", Inflamm Bowel Dis, 19, pp.1546~1555 (2013)
28. Tracey D, "Tumor necrosis factor antagonist mechanisms of action: a comprehensive review", Pharmacol Ther, 117, pp.244~279 (2008)
29. Inagaki-Ohara K, "p53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNF-TNFR1 system", Oncogene, 20, pp.812~818 (2001)
30. Liu H, "Blockade of hypoxia-inducible factor-1alpha by YC-1 attenuates interferon-gamma, tumor necrosis factor-alpha-induced intestinal epithelial barrier dysfunction", Cytokine, 56, pp.581~588 (2011)
31. Nagar M, "TNF activates a NF-kappaB-regulated cellular program in human CD45RA-regulatory T cells that modulates their suppressive function", J Immunol, 184, pp.3570~3581 (2010)
32. Biancheri P, "Proteolytic cleavage, loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease", Gastroenterology, 149, pp.1564~1574 (2015)
33. Nielsen OH, "Tumor necrosis factor inhibitors for inflammatory bowel disease", N Engl J Med, 369, pp.754~762 (2013)
34. Melmed GY, "Future biologic targets for IBD: potentials, pitfalls", Nat Rev Gastroenterol Hepatol, 7, pp.110~117 (2010)
35. Mahida YR, "High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis", Gut, 32, pp.1531~1534 (1991)
36. Mitsuyama K, "Colonic mucosal interleukin-6 in inflammatory bowel disease", Digestion, 50, pp.104~111 (1991)
37. Yamamoto M, "IL-6 is required for the development of Th1 cell-mediated murine colitis", J Immunol, 164, pp.4878~4882 (2000)
38. Akira S, "Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway", Cell, 77, pp.63~71 (1994)
39. Zhong Z, "Stat3 : a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor, interleukin-6", Science, 264, pp.95~98 (1994)
40. Takeda K, "Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation, characterization of T cell-specific Stat3-deficient mice", J Immunol, 161, pp.4652~4660 (1998)
41. Suzuki A, "CIS3", SOCS3, J Exp Med, pp.2001, 193[DOI]
42. Chapman RS, "Suppression of epithelial apoptosis, delayed mammary gland involution in mice with a conditional knockout of Stat3", Genes Dev, 13, pp.2604~2616 (1999)
43. Kim VN, "Biogenesis of small RNAs in animals", Nat Rev Mol Cell Biol, 10, pp.126~139 (2009)
44. Ghildiyal M, "Small silencing RNAs:an expanding universe", Nat Rev Genet, 10, pp.94~108 (2009)
45. Ishizu H, "Biology of PIWI-interacting RNAs: new insights into biogenesis, function inside, outside of germlines", Genes Dev, 26, pp.2361~2373 (2012)
46. Ha M, "Regulation of microRNA biogenesis", Nat Rev Mol Cell Biol, 15, pp.509~524 (2014)
47. Bushati N, "microRNA functions", Annu Rev Cell Dev Biol, 23, pp.175~205 (2007)
48. Saunders MA, "Human polymorphism at microRNAs, microRNA target sites", Proc Natl Acad Sci U S A, 104, pp.3300~3305 (2007)
49. Lee Y, "The nuclear RNase III Drosha initiates microRNA processing", Nature, 425, pp.415~419 (2003)
50. Chendrimada TP, "TRBP recruits the Dicer complex to Ago2 for microRNA processing, gene silencing", Nature, 436, pp.740~744 (2005)
51. Paraskevi A, "Circulating MicroRNA in inflammatory bowel disease", J Crohns Colitis, 6, pp.900~904 (2012)
52. Takagi T, "Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis", J Gastroenterol Hepatol, 25(Suppl 1), pp.S129~S133 (2010)
53. Yang Y, "Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB", Biochem Biophys Res Commun, 434, pp.746~752 (2013)
54. Shi C, "MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation, tissue injury", PLoS One, 8, pp.e66814~ (2013)
55. Kohlhaas S, "Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells", J Immunol, 182, pp.2578~2582 (2009)
56. Zheng Y, "Genome-wide analysis of Foxp3 target genes in developing, mature regulatory T cells", Nature, 445, pp.936~940 (2007)
57. Singh UP, "miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1", type 17 responses, 2014, pp.143, 478~489
58. Surajit Pathak, "MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis", Experimental and Molecular Medicine, 47, pp.1~9 (2015), 생화학분자생물학회
59. Svrcek M, "Overexpression of microRNAs-155, 21 targeting mismatch repair proteins in inflammatory bowel diseases", Carcinogenesis, 34, pp.828~834 (2013)
60. Lyda MH, "Microsatellite instability, K-ras mutations in patients with ulcerative colitis", Hum Pathol, 31, pp.665~671 (2000)
61. Coombes JL, "Dendritic cells in intestinal immune regulation", Nat Rev Immunol, 8, pp.435~446 (2008)
62. Zhou H, "MicroRNA-223 regulates the differentiation, function of intestinal dendritic cells, macrophages by targeting C", EBPbeta, 2015, pp.13, 1149~1160
63. Chen CZ, "MicroRNAs modulate hematopoietic lineage differentiation", Science, 303, pp.83~86 (2004)
64. Johnnidis JB, "Regulation of progenitor cell proliferation, granulocyte function by microRNA-223", Nature, 451, pp.1125~1129 (2008)
65. Lee J, "Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis", Sci Rep, 5, pp.18174~ (2015)
66. Nguyen HT, "Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy", Gastroenterology, 146, pp.508~519 (2014)
67. Archanioti P, "Micro-RNAs as regulators, possible diagnostic bio-markers in inflammatory bowel disease", J Crohns Colitis, 5, pp.520~524 (2011)

관련 논문AI추천